Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Scott Wilson Curtis Insider Profile
4 Followers
Scott Wilson Curtis, Executive Vice-President at Antibe Therapeutics, holds 115.00K shares in Antibe Therapeutics (Ticker: ATBPF). Most recently, Scott Wilson Curtis Bought $15,000 shares of Antibe Therapeutics on Mar 08, 2024 for an estimated value of 7.80K.
Scott Wilson Curtis Antibe Therapeutics (ATBPF)Executive Vice-President
Antibe Therapeutics (ATBPF)
Executive Vice-President
Ranked #4,751 out of 99,335 Corporate Insiders
Profitable Transactions
9 out of 18 Profitable Transactions
Average Return
+22.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Scott Wilson Curtis's holdings
Insider Roles
Executive Vice-President
Roles that Scott Wilson Curtis holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 26, 2017 - Jun 26, 2018
Return:+478.10%
The most profitable trade made by Scott Wilson Curtis
Scott Wilson Curtis's Trading History
List of latest transactions for each holding click on a transaction to see Scott Wilson Curtis's performance on stock
You May Also Like
Scott Wilson Curtis insider profile FAQ
What is the percentage of profitable transactions made by Scott Wilson Curtis?
The percentage of profitable transactions made by Scott Wilson Curtis is 50%.
What is the average return per transaction made by Scott Wilson Curtis?
The average return per transaction made by Scott Wilson Curtis is 22.10%.
What stocks does Scott Wilson Curtis hold?
Scott Wilson Curtis holds: ATBPF stocks.
What was Scott Wilson Curtis’s latest transaction?
Scott Wilson Curtis latest transaction was an Informative Buy of $7.80K.
What was Scott Wilson Curtis's most profitable transaction?
Scott Wilson Curtis’s most profitable transaction was an Informative Buy of ATBPF stock on June 26, 2017. The return on the trade was 478.10%.
What is Scott Wilson Curtis's role in Antibe Therapeutics?
Scott Wilson Curtis's role in Antibe Therapeutics is Executive Vice-President.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.